Skip to main content
Skip to content
Case File
d-22769House Oversight

California Institute of Regenerative Medicine awards multi‑million grants to stem‑cell biotech firms

Financial Record

The passage details public funding allocations to biotech companies but contains no allegations of misconduct, financial impropriety, or links to high‑level officials. It offers limited investigative CIRM allocated $10.1 M to ViaCyte, $9.3 M to Bluebird Bio, and up to $20 M each to StemCells Inc. fo Grants are part of CIRM’s Strategic Partnership Awards aimed at moving stem‑cell therapies toward

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #013483
Pages
2
Persons
8
Integrity
No Hash Available
Loading document viewer...

Ask AI About This Document

0Share
PostReddit
Review This Document

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.